Table 1. Demographics and characteristics of eligible population included in the analysis and those with incident cranial nerve palsy and incident stroke.
Eligible Population | Cranial Nerve Palsy | Stroke | |
---|---|---|---|
Number | 727,689 (100%) | 1,633 (100%) | 17,657 (100%) |
Demographics | |||
Sex | |||
Women | 370,269 (50.9%) | 728 (44.6%) | 8,538 (48.4%) |
Men | 357,420 (49.1%) | 905 (55.4%) | 9,119 (51.6%) |
Age group at diagnosis (years) | |||
20–39 | 339,306 (46.6%) | 232 (14.2%) | 1,177 (6.7%) |
40–59 | 268,953 (37.0%) | 765 (46.8%) | 5,477 (31.0%) |
60+ | 119,430 (16.4%) | 636 (38.9%) | 11,003 (62.3%) |
Residential Area | |||
Seoul and Incheon | 194,793 (26.8%) | 430 (26.3%) | 3,629 (20.6%) |
Gyeonggi and Gangwon | 174,442 (24.0%) | 372 (22.8%) | 3,849 (21.8%) |
Busan, Daegu, Ulsan, and Gyeongsang | 198,472 (27.3%) | 442 (27.1%) | 5,502 (31.2%) |
Daejeon, Sejong, and Chungcheong | 72,926 (10.0%) | 176 (10.8%) | 2,079 (11.8%) |
Gwangju, Jeola, and Jeju | 87,056 (12.0%) | 213 (13.0%) | 2,598 (14.7%) |
House Income | |||
Low income | 236,254 (32.5%) | 524 (32.1%) | 6,359 (36.0%) |
Middle income | 303,354 (41.7%) | 631 (38.6%) | 6,460 (36.6%) |
High income | 188,081 (25.8%) | 478 (29.3%) | 4,838 (27.4%) |
Comorbidity | |||
Hypertension | 80,830 (11.1%) | 505 (30.9%) | 6,551 (37.1%) |
Diabetes | 49,972 (6.9%) | 490 (30.0%) | 3,053 (17.3%) |
Ischemic Heart Disease | 24,178 (3.3%) | 144 (8.8%) | 1,759 (10.0%) |
Congestive Heart Failure | 9,480 (1.3%) | 52 (3.2%) | 959 (5.4%) |
Cancer | 16,903 (2.3%) | 76 (4.7%) | 752 (4.3%) |
Tuberculosis | 8,835 (1.2%) | 26 (1.6%) | 361 (2.0%) |
Peripheral Arterial Disease | 13,405 (1.8%) | 80 (4.9%) | 984 (5.6%) |
Atrial Fibrillation | 2,916 (0.4%) | 17 (1.0%) | 339 (1.9%) |
Chronic Kidney Disease | 1,472 (0.2%) | 13 (0.8%) | 126 (0.7%) |
Dyslipidemia | 49,835 (6.8%) | 304 (18.6%) | 2,449 (13.9%) |
Co-medication | |||
Anti-coagulant agents | 603 (0.1%) | 7 (0.4%) | 80 (0.5%) |
Anti-hypertensive agents | 33,360 (4.6%) | 244 (14.9%) | 2,822 (16.0%) |
Anti-platelet agents | 4,558 (0.6%) | 37 (2.3%) | 466 (2.6%) |
Hypoglycemic agents | 16 (0.0%) | 1 (0.1%) | 3 (0.0%) |